September 22, 2014 / 11:29 AM / 3 years ago

Auxilium says Endo's offer "significantly undervalues" company

Sept 22 (Reuters) - Auxilium Pharmaceuticals Inc said its board had determined that Endo International Plc’s offer “significantly undervalues” the company.

Endo made an unsolicited offer last week to buy Auxilium for about $2.2 billion.

Auxilium’s board also reiterated on Monday that it backed the company’s offer to buy Canadian eye drug maker QLT Inc . (Reporting by Ankur Banerjee in Bangalore; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below